|
Table of Contents:
Preface
Introduction
(Tom F. Parker, III)
1. Milestones in Dialysis
(Stephen Z. Fadem, Baylor College of Medicine, Houston, Texas USA and others)
2. The Course of Therapy – Changing the Paradigm
(Thomas A. Golper and Martin J. Schreiber, Jr.,Vanderbilt University Medical Center, Nashville, Tennessee, USA and others)
3. Accept this Kidney or Continue Dialysis? A Strategic Approach to Donor Options
(Amy L. Friedman, SUNY Upstate Medical University, Syracuse, New York, USA
4. Dialysis at Home - The Seattle Experience
(Chris Blagg, University of Washington, Seattle, USA and others
5. How do Clinical Outcomes of Automated Peritoneal Dialysis Compare with those of Continuous Ambulatory Peritoneal Dialysis?
(Sunil V. Badve, Carmel M. Hawley and David W. Johnson, Dept. of Nephrology, Princess Alexandra Hospital, Brisbane, Australia and others)
6. Intensified Hemodialysis Programs for Children and Adolescents
(Julia Thumfart and Dominik Müller, Dept. of Pediatric Nephrology, Charite Augustenburger Platz, Berlin, Germany)
7. The Wearable Artificial Kidney – A Paradigm Change in the Treatment of ESRD
(Victor Gura, Cedars Sinai Medical Center, Beverly Hills, California, USA)
8. Is Dialysis Ever An Inappropriate Therapy?
(Susan Higley Bray, Drexel University College of Medicine, Philadelphia, Pennsylvania, USA)
9. The Pre-eminent Role for Control of Extra-cellular Volume in Dialysis Therapy
(Richard J. Glassock, Geffen School of Medicine at UCLA, California, USA)
10. Mechanisms causing Muscle Wasting in Kidney Disease and other Catabolic conditions
(William E. Mitch, Nephrology Division, Baylor College of Medicine, Houston, Texas, USA
11. The Dysregulated Immune System of Patients on Dialysis
(Alexander Grabner, Hermann Pavenstädt, Detlef Lang and Stefan Reuter, Dept. of Medicine D, University of Munster, Germany)
12. Is Serum Albumin a Useful Marker of Nutritional Status in Chronic Kidney Disease?
(Allon N. Friedman, Division of Nephrology, Indiana University School of Medicine, Indianapolis, USA)
13. The Chronic Kidney Disease-Mineral Bone Disorder (CKD-MBD) and Vascular Calcification
(Keith A. Hruska, YifuFang and Toshifumi Sugatani, Washington University School of Medicine, St. Louis, Missouri, USA)
14. Update on Anemia and Kidney Disease
(Kiran M Goli, Arkadiy Pinkhasov, Daniel L Landry, Yossi Chait, Joseph Horowitz, Christopher V Hollot, Rajiv P Shrestha and Michael J Germain, Baystate Medical Center, University of Massachusetts at Amherst, USA and others)
15. Accumulation of Toxic Metals and Trace Elements in Chronic Dialysis Patients
(Tzung-Hai Yen, Dan-Tzu Lin-Tanand, Ja-Liang Lin, Chang Gung Memorial Hospital, Taipei, Taiwan)
16. Adequacy of Dialysis
(James Tattersall, Leeds Teaching Hospitals, UK)
17. The AV Fistula
(Fahad A. Syed and Eric K. Peden, The Methodist Hospital, Houston, TX, USA)
18. Cardiac Surgery in the End Stage Renal Disease Population:General Considerations, Risk Factors and Clinical Outcomes
(Javier E. Anaya-Ayala, Mark G. Davies and Michael J. Reardon,Methodist DeBakey Heart and Vascular Center, The Methodist Hospital, Houston, TX, USA and others)
19. Assessing Heath-Related Quality of Life with the KDQOL-36
(Dori Schatell, Executive Director, Medical Education Institute, Inc., Madison, Wisconsin, USA)
20. Integrated Renal Disease Care
(Franklin W. Maddux, Fresenius Medical Care Waltham, Massachusetts, USA)
Index |
